STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
Latest Information Update: 18 Oct 2024
At a glance
- Drugs Bicalutamide (Primary) ; Enzalutamide (Primary) ; Gonadotropin releasing hormone stimulants
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms STEEL
- 04 Jun 2024 Results assessing safety and efficacy of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 27 Jan 2024 Initial results (n=188) presented at the 2024 Genitourinary Cancers Symposium.
- 01 Jun 2023 Status changed from recruiting to active, no longer recruiting.